FDA issues warning on anti-smoking drugs
The FDA has issued a warning for the anti-smoking drugs Chantix and Zyban as bizarre behavior, including suicide, has been seen in people taking these medicines. Both drugs will now carry “black box” labels warning informing people that those consuming these drugs should be closely watched for signs of suicidal thoughts, depression, hostility or other changes in behavior.
- FDA warning letter to Baxa
- New Treatment Hope For People With Recurring Depression
- Avandia linked to a rise in liver, heart and bone density problems
- Study links ibuprofen to lower risk of Alzheimer’s disease
